CAS 160948-33-4: 2-Pyrimidinamine, 4-methyl-5-nitro-6-(phenylmethoxy)-

4-(benzyloxy)-6-methyl-5-nitropyrimidin-2-amine is an imine that is synthesized from benzaldehyde and 2,4,6-trinitrobenzenesulfonic acid. It is a convergent synthesis. 4-(benzyloxy)-6-methyl-5-nitropyrimidin-2-amine has been shown to be biologically active in the treatment of chronic myelogenous leukemia.